Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

End-stage COPD is the most severe stage of chronic ... A spacer is a small plastic tube that attaches to your inhaler. The medication moves into the spacer, where it becomes a fine mist that ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Treatment for COPD can include medications, such as inhalers; oxygen; pulmonary rehabilitation; in-home noninvasive ventilation therapy; managing flare-ups, also called exacerbations ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

or the drugs themselves. The jury is still out because budesonide-containing dry-powder inhalers for COPD are not on the U.S. market -- and therefore not available for a comparison of dry-powder ...